Market News (Page 50) - TendieTensor

Market News Page 50 of 159 • 3,956 articles

MRX DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Marex Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRX

GlobeNewswire Inc. • Rosen Law Firm

MRX DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Marex Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRX

11/16/2025 12:36 PM • Rosen Law Firm is notifying Marex Group plc investors about a securities class action lawsuit alleging financial misstatements and misleading disclosures during the period of May 16, 2024 to August 5, 2025.

BACpL - Buffett sold 41% of Berkshire's stake due to potential interest rate sensitivity, high valuation premium, and potential future tax considerations
MRX - The lawsuit alleges the company made false/misleading statements about its financial instruments, intercompany transactions, and financial statements, suggesting potential financial misconduct

#securities class action #financial misstatements #investor rights

CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cytokinetics, Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc

CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cytokinetics, Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

11/16/2025 12:00 PM • A class action lawsuit has been filed against Cytokinetics for allegedly making false and misleading statements about its New Drug Application timeline and FDA approval process for aficamten, potentially misrepresenting regulatory risks.

BACpK - Buffett sold 41% of Berkshire's stake due to potential interest rate sensitivity, high valuation premium, and potential future tax considerations
CYTK - The lawsuit alleges the company made materially false statements about its drug application timeline, misrepresented FDA approval expectations, and failed to disclose critical regulatory risks, suggesting potential corporate misconduct

#class action #securities lawsuit #FDA approval #drug application #investor alert

FLYY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Spirit Aviation Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc

FLYY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Spirit Aviation Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

11/16/2025 12:00 PM • Law firm announces class action lawsuit against Spirit Aviation Holdings for allegedly making false and misleading statements about the company's financial condition and potential bankruptcy risk during May-August 2025.

BACpE - Buffett sold 41% of Berkshire's stake due to potential interest rate sensitivity, high valuation premium, and potential future tax considerations
FLYYQ - Lawsuit alleges company made false statements about financial health, was at risk of bankruptcy, and potentially misrepresented its financial condition and market challenges

#class action #securities lawsuit #financial disclosure #bankruptcy risk

Kamirai Announces Cross-Platform AAA Action-RPG Title in Development, Targeting Simultaneous Release on PlayStation, Xbox, and PC

GlobeNewswire Inc. • Kenjiro Matsuda

Kamirai Announces Cross-Platform AAA Action-RPG Title in Development, Targeting Simultaneous Release on PlayStation, Xbox, and PC

11/16/2025 09:56 AM • Kamirai is developing a next-generation open-world Action RPG targeting simultaneous release on PlayStation, Xbox, and PC, with an integrated decentralized token economy aimed at bridging traditional gaming and Web3 experiences.

GOOGL - Reported record quarterly revenue of over $100 billion, demonstrated double-digit growth in Google Services and Cloud, and increased investment in AI infrastructure
SONY - Mentioned as a target platform for game release, with no specific positive or negative implications

#Web3 #Action RPG #Blockchain #Gaming #Cross-Platform #Decentralized Finance

Shareholders who lost money in shares of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Should Contact Wolf Haldenstein Immediately

GlobeNewswire Inc. • Wolf Haldenstein Adler Freeman & Herz Llp

Shareholders who lost money in shares of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Should Contact Wolf Haldenstein Immediately

11/16/2025 09:35 AM • Telix Pharmaceuticals is under investigation by the SEC for potential misrepresentations about its prostate cancer therapeutic candidates and drug pipeline, leading to significant stock price declines.

AMD - Mentioned as a competitor to Nvidia in the GPU market, but no specific performance details were provided
TLX - Company faced SEC subpoena, stock price dropped multiple times due to disclosure concerns about drug pipeline, and potential misrepresentation of progress in prostate cancer therapeutic candidates

#SEC #subpoena #prostate cancer #securities litigation #stock price

GlobeNewswire Inc. • Wolf Haldenstein Adler Freeman & Herz Llp

Shareholders who lost money in shares of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Should Contact Wolf Haldenstein Immediately

11/16/2025 09:33 AM • Telix Pharmaceuticals is facing a potential securities class action lawsuit alleging misrepresentations about its prostate cancer therapeutic candidates and supply chain operations, following an SEC subpoena and subsequent stock price declines.

TLX - Company experienced significant stock price drops after SEC subpoena, potential misrepresentations about drug pipeline, and receiving a Complete Response Letter from FDA for a renal cancer drug candidate

#securities lawsuit #SEC subpoena #pharmaceutical #prostate cancer #stock decline

IREN, CoreWeave, And IonQ Are Among Top 10 Large Cap Losers Last Week (Nov. 10-Nov. 14): Are the Others in Your Portfolio?

Benzinga • Nabaparna Bhattacharya

IREN, CoreWeave, And IonQ Are Among Top 10 Large Cap Losers Last Week (Nov. 10-Nov. 14): Are the Others in Your Portfolio?

11/16/2025 09:31 AM • Multiple large-cap stocks experienced significant declines last week, with crypto-linked and tech stocks being particularly impacted by market weakness, Bitcoin price drops, and lowered financial guidance.

BACpB - Buffett sold 41% of Berkshire's stake due to potential interest rate sensitivity, high valuation premium, and potential future tax considerations
IREN - Fell 29.3% due to crypto-linked stock trading lower and Bitcoin price drop

#large cap stocks #market decline #Bitcoin #tech stocks #financial guidance

History Says Buying Target Stock at a 5% Dividend Yield Is a Good Move. But Is It?

The Motley Fool • Jon Quast

History Says Buying Target Stock at a 5% Dividend Yield Is a Good Move. But Is It?

11/16/2025 08:33 AM • Target, a Dividend King with 55 consecutive years of dividend increases, is experiencing sales challenges but shows potential growth in digital revenue streams like advertising and third-party marketplace. Despite current struggles, the stock trades at an attractive valuation with a high dividend yield.

TGT - The company is facing sales declines and margin pressures, but has promising digital revenue growth, a long history of navigating challenges, and trades at an attractive valuation with a high dividend yield

#dividend #retail #stock valuation #digital revenue #Target

Maplebear, Tower Semiconductor, And Eli Lilly Are Among the Top 10 Large-Cap Gainers Last Week (Nov. 10-Nov. 14): Are the Others in Your Portfolio?

Benzinga • Nabaparna Bhattacharya

Maplebear, Tower Semiconductor, And Eli Lilly Are Among the Top 10 Large-Cap Gainers Last Week (Nov. 10-Nov. 14): Are the Others in Your Portfolio?

11/16/2025 08:31 AM • Several large-cap stocks showed significant gains last week, with companies like On Holding, Albemarle, and Tower Semiconductor reporting strong earnings and receiving positive analyst attention.

GOOG - Reported record quarterly revenue of over $100 billion, demonstrated double-digit growth in Google Services and Cloud, and increased investment in AI infrastructure
ONON - Gained 14.8% after reporting Q3 earnings above estimates and receiving multiple analyst price target upgrades

#large-cap stocks #earnings #stock performance #quarterly results

Is GigaCloud Stock a Buy or Sell After Its COO Dumped Shares Worth Nearly $3 Million?

The Motley Fool • Robert Izquierdo

Is GigaCloud Stock a Buy or Sell After Its COO Dumped Shares Worth Nearly $3 Million?

11/15/2025 11:36 PM • GigaCloud Technology's COO, Xinyan Hao, sold 90,000 shares worth $2.8 million, reducing his holdings to 596,805 shares. Despite the sale, the company shows strong financial performance with Q3 sales rising 10% and a solid balance sheet.

BApA - Referenced in context of Southwest's fleet upgrade with more fuel-efficient 737 MAX aircraft, with no direct sentiment assessment.
GCT - Strong Q3 performance with 10% year-over-year sales growth, excellent balance sheet with $1.1B in total assets, no debt, and continued executive confidence as COO retains over 596,000 shares after selling

#insider trading #stock sale #B2B e-commerce #cross-border platform #large parcel goods

CYTK DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important November 17 Deadline in Securities Class Action – CYTK

GlobeNewswire Inc. • Rosen Law Firm

CYTK DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important November 17 Deadline in Securities Class Action – CYTK

11/15/2025 07:52 PM • Rosen Law Firm alerts Cytokinetics investors about a securities class action lawsuit regarding potential misleading statements about a New Drug Application timeline and FDA approval process for aficamten.

BA - Referenced in context of Southwest's fleet upgrade with more fuel-efficient 737 MAX aircraft, with no direct sentiment assessment.
CYTK - Lawsuit alleges company made false or misleading statements about drug application timeline and failed to disclose material risks that could delay regulatory approval, suggesting potential investor harm

#securities class action #FDA #drug approval #investor rights

ROSEN, A HIGHLY RANKED LAW FIRM, Encourages CarMax, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – KMX

GlobeNewswire Inc. • Rosen Law Firm

ROSEN, A HIGHLY RANKED LAW FIRM, Encourages CarMax, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – KMX

11/15/2025 06:50 PM • Rosen Law Firm is notifying CarMax investors about a securities class action lawsuit alleging false statements about the company's growth prospects during the period of June 20, 2025 to November 5, 2025.

KMX - The lawsuit alleges that CarMax made materially false and misleading statements about its growth prospects, suggesting the company potentially misrepresented its financial performance and market position

#securities #class action #lawsuit #investor rights

ROSEN, A HIGHLY RANKED LAW FIRM, Encourages Avantor, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AVTR

GlobeNewswire Inc. • Rosen Law Firm

ROSEN, A HIGHLY RANKED LAW FIRM, Encourages Avantor, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AVTR

11/15/2025 05:48 PM • Rosen Law Firm alerts Avantor investors about a potential securities class action lawsuit alleging misrepresentation of the company's competitive positioning and business prospects during the period of March 5, 2024 to October 28, 2025.

XLE - Referenced as a benchmark with a 2.1% average yield, used for comparative purposes in the article
AVTR - The lawsuit suggests the company misrepresented its competitive positioning, experienced negative effects from increased competition, and made materially false or misleading statements about its business operations and prospects

#securities #class action #investor rights #lawsuit

Class Action Announcement for Firefly Aerospace Inc. (FLY): Kessler Topaz Meltzer & Check, LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Firefly Aerospace Inc.

GlobeNewswire Inc. • Kessler Topaz Meltzer & Check, Llp

Class Action Announcement for Firefly Aerospace Inc. (FLY): Kessler Topaz Meltzer & Check, LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Firefly Aerospace Inc.

11/15/2025 10:45 AM • A securities class action lawsuit has been filed against Firefly Aerospace Inc. alleging false statements about company's spacecraft solutions, rocket program readiness, and business prospects during its IPO period.

XLE - Used as a benchmark for sector performance, showing modest positive movement in the article
FLY - Lawsuit alleges company made materially false and misleading statements about business operations, growth prospects, and rocket program's commercial viability during its IPO period

#securities lawsuit #class action #IPO #rocket program #spacecraft solutions

The Motley Fool • Adam Spatacco

"Big Short" Money Manager Michael Burry Just Bet Against Nvidia and Palantir. Is He Calling the Top of the Artificial Intelligence (AI) Boom?

11/15/2025 10:33 AM • Renowned investor Michael Burry has opened short positions against Nvidia and Palantir, potentially signaling concerns about the AI sector's valuation and potential market correction.

NVDA - High AI infrastructure spending and strong market position, but potential valuation concerns and increasing competition from rivals

#AI #short selling #market correction #technology stocks #valuation

Prediction: Archer Aviation Could Soar 50% by 2026 if This Happens

The Motley Fool • Rick Orford

Prediction: Archer Aviation Could Soar 50% by 2026 if This Happens

11/15/2025 10:32 AM • Archer Aviation is progressing from prototypes to production with its Midnight model, exploring early operations in Abu Dhabi and working towards certification, potentially setting the stage for significant growth by 2026.

MPC - Mentioned as the majority owner of MPLX, collecting $2.5 billion annually in cash payments, with no specific performance commentary
ACHR - The article suggests potential 50% stock price growth by 2026, highlighting the company's progress in developing electric vertical takeoff and landing (eVTOL) aircraft, advancing from prototypes to production, and exploring initial operational routes

#electric aviation #eVTOL #transportation technology #certification #production

Got $5,000? 3 Tech Stocks to Buy and Hold for the Long Term.

The Motley Fool • Leo Sun

Got $5,000? 3 Tech Stocks to Buy and Hold for the Long Term.

11/15/2025 08:35 AM • The article highlights three tech stocks with potential long-term growth: Quantum Computing Inc., Innodata, and Figma. Each company offers unique technological advantages in quantum computing, AI data preparation, and design software, respectively, making them attractive for investors seeking future-oriented investments.

KMI - Mixed performance with attractive dividend but high payout ratio and year-to-date stock decline suggest caution. Analysts mostly rate it a buy, but with reservations about growth potential.
QUBT - Developing innovative photonic chips that can operate at room temperature, with potential to revolutionize quantum computing market and expected revenue growth from $407,000 in 2025 to $10.2 million in 2027

#quantum computing #AI #tech stocks #long-term investing #cloud-based services